Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit

9Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dabigatran is a direct thrombin inhibitor indicated for thromboembolism prophylaxis in patients with non-valvular atrial fibrillation. The procedure to manage dabigatran-associated haemorrhages is not well formalized. Conventional haemodialysis has been evaluated with good results. Patients with dabigatran-associated bleeding may be unstable and convective techniques like venovenous haemodiafiltration (HDF) can be interesting. We report the case of a 74-year-old, critically ill patient with haemorrhagic shock and dabigatran overexposure due to acute kidney injury. He underwent HDF and dabigatran blood concentrations decreased from 325.3 ng/mL to 160.5 ng/mL. We report here key pharmacokinetics parameters (half-life, extraction coefficient, clearance).

Cite

CITATION STYLE

APA

Claisse, G., Delavenne, X., Masson, I., Maillard, N., Alamartine, E., & Mariat, C. (2015). Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit. Clinical Kidney Journal, 8(2), 199–201. https://doi.org/10.1093/ckj/sfv001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free